Synthesis and Pharmacology of α/β(3)-Peptides Based on the Melanocortin Agonist Ac-His-dPhe-Arg-Trp-NH2 Sequence.
暂无分享,去创建一个
[1] Manuela Grimaldi,et al. 1,4-Disubstituted-[1,2,3]triazolyl-Containing Analogues of MT-II: Design, Synthesis, Conformational Analysis, and Biological Activity , 2014, Journal of medicinal chemistry.
[2] C. Haskell-Luevano,et al. Melanocortin ligands: 30 years of structure–activity relationship (SAR) studies , 2004, Medicinal research reviews.
[3] M. Mortrud,et al. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.
[4] D. Seebach,et al. On the Biodegradation of β‐Peptides , 2002 .
[5] R. Mains,et al. Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. , 1980, Endocrine reviews.
[6] D. Seebach,et al. The outstanding biological stability of beta- and gamma-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases. , 2001, Chembiochem : a European journal of chemical biology.
[7] V. Hruby,et al. Truncation studies of α-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity , 1996, Peptides.
[8] V J Hruby,et al. alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. , 1987, Journal of medicinal chemistry.
[9] U. Samanta,et al. Packing of aromatic rings against tryptophan residues in proteins. , 1999, Acta crystallographica. Section D, Biological crystallography.
[10] R. Cone,et al. Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.
[11] A. Edison,et al. Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMR. , 2011, Journal of medicinal chemistry.
[12] W. Millard,et al. Implication of the melanocortin-3 receptor in the regulation of food intake. , 2011, European journal of pharmacology.
[13] S. Salvadori,et al. Structural and biological exploration of phe(3)-phe(4)-modified endomorphin-2 peptidomimetics. , 2013, ACS medicinal chemistry letters.
[14] S. Mammi,et al. Conformational and biological characterization of human parathyroid hormone hPTH(1–34) analogues containing β‐amino acid residues in positions 17–19 , 2003, Biopolymers.
[15] T K Sawyer,et al. Alpha-melanotropin: the minimal active sequence in the lizard skin bioassay. , 1989, General and comparative endocrinology.
[16] Ximena Opitz-Araya,et al. Exocrine Gland Dysfunction in MC5-R-Deficient Mice: Evidence for Coordinated Regulation of Exocrine Gland Function by Melanocortin Peptides , 1997, Cell.
[17] James Gardiner,et al. Beta-peptidic peptidomimetics. , 2008, Accounts of chemical research.
[18] V J Hruby,et al. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R. , 1997, Journal of medicinal chemistry.
[19] D. Hoyer,et al. β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.
[20] M. Mortrud,et al. The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.
[21] A. Levine,et al. Synthesis, Biophysical, and Pharmacological Evaluation of the Melanocortin Agonist AST3-88: Modifications of Peptide Backbone at Trp 7 Position Lead to a Potent, Selective, and Stable Ligand of the Melanocortin 4 Receptor (MC4R) , 2014, ACS chemical neuroscience.
[22] C. Haskell-Luevano,et al. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors. , 2001, Journal of medicinal chemistry.
[23] S. Watson,et al. Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.
[24] A. Glättli,et al. Helices and other secondary structures of beta- and gamma-peptides. , 2006, Biopolymers.
[25] R. Cone,et al. A Unique Metalolic Sysdrone Causes Obesity in the Melanocortin-3 Receptor-Deficient Mouse. , 2000, Endocrinology.
[26] R. Cone,et al. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. , 2000, Endocrinology.
[27] Yue Feng,et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.
[28] D. Seebach,et al. On the biodegradation of beta-peptides. , 2002, Chembiochem : a European journal of chemical biology.
[29] D. Hoyer,et al. Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptors. , 2003, Naunyn-Schmiedeberg's archives of pharmacology.
[30] M. Mortrud,et al. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Seebach,et al. The Outstanding Biological Stability of β‐ and γ‐Peptides toward Proteolytic Enzymes: An In Vitro Investigation with Fifteen Peptidases , 2001 .
[32] J. Wikberg,et al. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.
[33] Victor J. Hruby,et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.
[34] S. Watson,et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.
[35] A. Glättli,et al. Helices and other secondary structures of β‐ and γ‐peptides , 2006 .
[36] Y. Konda,et al. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. , 1994, Biochemical and biophysical research communications.
[37] V. Hruby,et al. Biological active analogues of the opioid peptide biphalin: mixed α/β(3)-peptides. , 2013, Journal of medicinal chemistry.